In multiple myeloma, which is characterized by chromosomal aberrations including MYC amplification, JQ1 showed significant effects in abrogating MYC oncogenic function and also reduced MYC expression (Delmore et al., 2011). The gene discussed is MYC; the disease is AL amyloidosis.